Source:http://linkedlifedata.com/resource/pubmed/id/12176897
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
2002-8-14
|
pubmed:abstractText |
Lymphoblastoid cell lines (LCLs) are human B cells latently infected and immortalized by Epstein-Barr virus (EBV). Presenting viral antigens, they efficiently induce EBV-specific T-cell responses in vitro. Analogous ways to generate T-cell cultures specific for other antigens of interest are highly desirable. Previously, we constructed a mini-EBV plasmid that consists of less than half the EBV genome, is unable to cause virus production, but still immortalizes B cells in vitro. Mini-EBV-immortalized B-cell lines (mini-LCLs) are efficiently produced by infection of B cells with viruslike particles carrying only mini-EBV DNA. Mini-EBV plasmids can be engineered to express an additional gene in immortalized B cells. Here we present a mini-EBV coding for a potent CD8(+) T-cell antigen, the matrix phosphoprotein pp65 of human cytomegalovirus (CMV). By means of this pp65 mini-EBV, pp65-expressing mini-LCLs could be readily established from healthy donors in a one-step procedure. We used these pp65 mini-LCLs to reactivate and expand effector T cells from autologous peripheral blood cells in vitro. When generated from cytomegalovirus (CMV)-seropositive donors, these effector T-cell cultures displayed strong pp65-specific HLA-restricted cytotoxicity. A large fraction of CD8(+) T cells with pp65 epitope specificity was present in such cultures, as demonstrated by direct staining with HLA/peptide tetramers. We conclude that the pp65 mini-EBV is an attractive tool for CMV-specific adoptive immunotherapy. Mini-EBVs could also facilitate the generation of T cells specific for various other antigens of interest.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0006-4971
|
pubmed:author |
pubmed-author:BlakeNeil WNW,
pubmed-author:CobboldMarkM,
pubmed-author:Croom-CarterDebbieD,
pubmed-author:DelecluseHenri-JacquesHJ,
pubmed-author:HammerschmidtWolfgangW,
pubmed-author:HislopAndrew DAD,
pubmed-author:HollweckGabiG,
pubmed-author:KhanNaeemN,
pubmed-author:MoosmannAndreasA,
pubmed-author:MossPaul A HPA,
pubmed-author:RickinsonAlan BAB,
pubmed-author:WollenbergBarbaraB,
pubmed-author:ZeidlerReinhardR,
pubmed-author:ZentzCarolineC
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
100
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1755-64
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:12176897-Antigens, Viral,
pubmed-meshheading:12176897-B-Lymphocytes,
pubmed-meshheading:12176897-Cell Transformation, Viral,
pubmed-meshheading:12176897-Cells, Cultured,
pubmed-meshheading:12176897-Epitopes, T-Lymphocyte,
pubmed-meshheading:12176897-Herpesvirus 4, Human,
pubmed-meshheading:12176897-Humans,
pubmed-meshheading:12176897-Lymphocyte Activation,
pubmed-meshheading:12176897-Lymphocyte Cooperation,
pubmed-meshheading:12176897-T-Lymphocytes, Cytotoxic
|
pubmed:year |
2002
|
pubmed:articleTitle |
B cells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells.
|
pubmed:affiliation |
Department of Otorhinolaryngology, Ludwig-Maximilians-Universität, Munich, Germany. moosmann@hno.med.uni-muenchen.de
|
pubmed:publicationType |
Journal Article
|